Avicanna Provides Corporate Update and Preliminary Q2 Results
TORONTO, June 28, 2023 (GLOBE NEWSWIRE) — Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN)…
Logistics
Nkarta Updates Clinical Progress of CAR-NK Cell Therapy NKX101 for Patients with Relapsed or Refractory Acute Myeloid Leukemia
Encouraging antileukemic activity seen with NKX101 in patients with AML, including several with high-risk features,…
Nkarta Updates Clinical Progress of CAR-NK Cell Therapy NKX101 for Patients with Relapsed or Refractory Acute Myeloid Leukemia
Encouraging antileukemic activity seen with NKX101 in patients with AML, including several with high-risk features,…
Tilray Brands Completes Accretive Acquisition of HEXO Corp. Leading the Next Evolution of Canadian Cannabis
Creates Canada’s Largest Cannabis Company by Revenue and Increases Tilray’s #1 Leading Cannabis Share by…
Tilray Brands Completes Accretive Acquisition of HEXO Corp. Leading the Next Evolution of Canadian Cannabis
Creates Canada’s Largest Cannabis Company by Revenue and Increases Tilray’s #1 Leading Cannabis Share by…
Better Choice Announces Strategic Investment from Alphia of $5 Million, Establishes Multi-Year Manufacturing Partnership
The investment will restructure company debt, supporting sustainable, long-term business growth NEW YORK, June 22,…
FBI approves QIAGEN’s NGS-based ForenSeq MainstAY workflow for the U.S. National DNA Index System (NDIS)
NDIS approval provides access to federal government funding for accredited public crime laboratories in the…
FBI approves QIAGEN’s NGS-based ForenSeq MainstAY workflow for the U.S. National DNA Index System (NDIS)
NDIS approval provides access to federal government funding for accredited public crime laboratories in the…
Intelligent Bio Solutions Receives Non-Dilutive Grant Funding of USD $1.43 Million
Grant Funding received to date from the Australian Federal Government totals USD $3.25 million NEW…
Intelligent Bio Solutions Receives Non-Dilutive Grant Funding of USD $1.43 Million
Grant Funding received to date from the Australian Federal Government totals USD $3.25 million NEW…
QIAGEN provides reminder on settlement mechanics of 2023 and 2024 convertible notes
Venlo, the Netherlands, June 16, 2023 (GLOBE NEWSWIRE) — QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime…
QIAGEN provides reminder on settlement mechanics of 2023 and 2024 convertible notes
Venlo, the Netherlands, June 16, 2023 (GLOBE NEWSWIRE) — QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime…
One World Products Issues Shareholder Update Letter Providing Review of 2022 and Business Outlook for 2023
Expects Extraction and Production Facility to be Operational Before the End of the Third Quarter…
One World Products Issues Shareholder Update Letter Providing Review of 2022 and Business Outlook for 2023
Expects Extraction and Production Facility to be Operational Before the End of the Third Quarter…
Hyloris has been granted EUR 1 million in non-dilutive funding from the Walloon Region
Regulated Information – Liège, Belgium – 08 June 2023 – 6 PM CET – Hyloris Pharmaceuticals SA…
Hyloris has been granted EUR 1 million in non-dilutive funding from the Walloon Region
Regulated Information – Liège, Belgium – 08 June 2023 – 6 PM CET – Hyloris Pharmaceuticals SA…
Galapagos to showcase CAR-T point-of-care manufacturing and initial Phase 1/2 CLL data with CD19 CAR-T candidate, GLPG5201, at the EHA 2023 congress
All 7 out of 7 eligible patients with relapsed/refractory chronic lymphocytic leukemia (rrCLL), with or…
Galapagos to showcase CAR-T point-of-care manufacturing and initial Phase 1/2 CLL data with CD19 CAR-T candidate, GLPG5201, at the EHA 2023 congress
All 7 out of 7 eligible patients with relapsed/refractory chronic lymphocytic leukemia (rrCLL), with or…
Clover Expands Sales and Distribution Network for Upcoming Quadrivalent Seasonal Influenza Vaccine Launch in China
— Clover to leverage Kyuan Trade’s extensive sales and distribution network to complement in-house capabilities…
Celularity Announces $45 Million Purchase Order, First Middle East Private Label Agreement For Celularity’s Halal-Certified Biomaterial Products
Builds on Celularity’s December 2022 announcement of Halal Certification of its commercial-stage biomaterial products, and…